- Circulating serum oncologic miRNA in pediatric juvenile pilocytic astrocytoma patients predicts mural nodule volume
Markus Bookland et al, 2018, Acta Neurochir CrossRef - MicroRNAs as a drug resistance mechanism to targeted therapies in EGFR-mutated NSCLC: current implications and future directions
Alessandro Leonetti et al, 2018, Drug Resistance Updates CrossRef - microRNA-23a in Human Cancer: Its Roles, Mechanisms and Therapeutic Relevance
Ning Wang et al, 2018, Cancers CrossRef - Apoptotic suppression of inflammatory macrophages and foam cells in vascular tissue by miR-23a
Rabih Roufayel et al, 2019, Health Technol. CrossRef - Inhibition of long noncoding RNA growth arrest–specific 5 attenuates cerebral injury induced by deep hypothermic circulatory arrest in rats
Shilun Gao et al, 2019, The Journal of Thoracic and Cardiovascular Surgery CrossRef - The Roles of MicroRNA in Lung Cancer
Kuan-Li Wu et al, 2019, IJMS CrossRef - Interactive functions of microRNAs in the miR‐23a‐27a‐24‐2 cluster and the potential for targeted therapy in cancer
Mengying Cui et al, 2019, J Cell Physiol CrossRef - AAV9-mediated delivery of miR-23a reduces disease severity in Smn2B/−SMA model mice
Kevin A Kaifer et al, 2019 CrossRef - PTEN Tumor-Suppressor: The Dam of Stemness in Cancer
Francesca Luongo et al, 2019, Cancers CrossRef - Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies
null Khan et al, 2019, Cells CrossRef - Targeting Autophagy for Overcoming Resistance to Anti-EGFR Treatments
Yoojung Kwon et al, 2019, Cancers CrossRef - The Importance of microRNAs in RAS Oncogenic Activation in Human Cancer
Roberta Roncarati et al, 2019, Front. Oncol. CrossRef - NF-κB-Induced Upregulation of miR-548as-3p Increases Invasion of NSCLC by Targeting PTEN
Sakir Akgun et al, 2019, ACAMC CrossRef - miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer
Peng Ge et al, 2019, BMC Cancer CrossRef - MicroRNA-23a-3p improves traumatic brain injury through modulating the neurological apoptosis and inflammation response in mice
Zhikun Li et al, 2019, Cell Cycle CrossRef - The emerging treatment landscape of targeted therapy in non-small-cell lung cancer.
Min Yuan et al, 2019, Signal Transduct Target Ther CrossRef - SNHG5 enhances Paclitaxel sensitivity of ovarian cancer cells through sponging miR-23a
Huilong Lin et al, 2020, Biomedicine & Pharmacotherapy CrossRef - MicroRNA-23a suppresses the apoptosis of inflammatory macrophages and foam cells in atherogenesis by targeting HSP90
Yu Qiao et al, 2019, Gene CrossRef - Increased Expression of Micro-RNA-23a Mediates Chemoresistance to Cytarabine in Acute Myeloid Leukemia.
Stefan Hatzl et al, 2020, Cancers (Basel) CrossRef - Gastric Cancer Cell-Derived Exosomal microRNA-23a Promotes Angiogenesis by Targeting PTEN
Jiang Du et al, 2020, Front. Oncol. CrossRef - Current Strategies for Treating NSCLC: From Biological Mechanisms to Clinical Treatment.
Hang fai Kwok, 0 CrossRef - Pristimerin enhances the effect of cisplatin by inhibiting the miR‑23a/Akt/GSK3β signaling pathway and suppressing autophagy in lung cancer cells
Yingbing Zhang et al, 2019, Int J Mol Med CrossRef - MiR-204 reduces cisplatin resistance in non-small cell lung cancer through suppression of the caveolin-1/AKT/Bad pathway
Gang Huang et al, 2019, Aging CrossRef - Targeting Akt-associated microRNAs for cancer therapeutics
Mir S. Adil et al, 2020, Biochemical Pharmacology CrossRef - Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers
Asal Jalal Abadi et al, 2021, Biomolecules CrossRef - Serum Extracellular Vesicle-Derived miRNAs in Patients with Non-Small Cell Lung Cancer—Search for Non-Invasive Diagnostic Biomarkers
Jolanta Kryczka et al, 2021, Diagnostics CrossRef - HYD-PEP06 suppresses hepatocellular carcinoma metastasis, epithelial–mesenchymal transition and cancer stem cell-like properties by inhibiting PI3K/AKT and WNT/β-catenin signaling activation
Wei Tian et al, 2021, Acta Pharmaceutica Sinica B CrossRef - Inhibition of miR-185-3p Confers Erlotinib Resistance Through Upregulation of PFKL/MET in Lung Cancers
Ke Li et al, 2021, Front. Cell Dev. Biol. CrossRef - Therapeutic Targeting of Cancer Stem Cells in Lung, Head and Neck, and Bladder Cancers
Sarah E. Mudra et al, 2021, Cancers CrossRef - MicroRNAs as the critical regulators of tyrosine kinase inhibitors resistance in lung tumor cells
Amirhosein Maharati et al, 2022, Cell Commun Signal CrossRef - Restoration of miR-23a expression by chidamide sensitizes CML cells to imatinib treatment with concomitant downregulation of CRYAB
Xunxun Zhu et al, 2022, Bioengineered CrossRef - The molecular mechanism of circRHOBTB3 inhibits the proliferation and invasion of epithelial ovarian cancer by serving as the ceRNA of miR-23a-3p
Yihan Fu et al, 2022, J Ovarian Res CrossRef - Emerging strategies to overcome resistance to third-generation EGFR inhibitors
Kunyu Shi et al, 2022, J Hematol Oncol CrossRef - Panoramic view of microRNAs in regulating cancer stem cells
Yongzhi Zhao et al, 2022 CrossRef - Circ_SETD3 regulates gefitinib sensitivity and tumor progression by miR-873-5p-dependent regulation of APPBP2 in non-small cell lung cancer.
Jun Sheng et al, 2021, J Chemother CrossRef - null
Maksat Babayev et al, 2022 CrossRef - Morphine-mediated release of astrocyte-derived extracellular vesicle miR-23a induces loss of pericyte coverage at the blood-brain barrier: Implications for neuroinflammation
Ke Liao et al, 2022, Front. Cell Dev. Biol. CrossRef - null
Kewen Qian et al, 2023 CrossRef - A literature review of microRNA and gene signaling pathways involved in the apoptosis pathway of lung cancer
Hanie Abolfathi et al, 2023, Respir Res CrossRef - Advances in the role of microRNAs associated with the PI3K/AKT signaling pathway in lung cancer
Yanting Wang et al, 2023, Front. Oncol. CrossRef - null
Ritu Shekhar et al, 2024 CrossRef